Valuation-driven coverage, with a focus on quality businesses in the US small and mid-cap universe.

Report 01 · Software · CSU:CN · TSX

Constellation Software (CSU): acquisition-compounding machine; ROIC on capital deployment is the investment case.

Buy. Serial acquirer of vertical market software with 30%+ sustained ROIC on deployed capital; high gross revenue retention and a still-fragmented addressable acquisition universe support durable long-duration compounding.

Investment thesis: CSU's edge is not simply "buy and hold"; it is a repeatable acquisition methodology applied to niche vertical market software (VMS) businesses at disciplined IRR thresholds, a channel that remains structurally uncrowded relative to the breadth of the addressable VMS universe. Our analysis supports three convictions: (1) gross revenue retention of 95%+ across the portfolio is the FCF quality anchor: CSU does not need growth to generate cash; (2) ROIC on cumulative acquired capital has held above 30% for a decade, the clearest signal of acquisition discipline; (3) the Topicus spin-out demonstrates that the model scales internationally without ROIC dilution, extending the runway for capital deployment. At current prices, investors are paying a mid-20s FCF multiple for a business that can compound intrinsic value at 20%+ annually if deployment velocity is maintained.

Key drivers: (1) M&A pipeline depth: fragmented VMS market globally; addressable universe of acquisition targets still counts in the thousands. (2) Topicus growth: European VMS penetration still early; adds an independent capital deployment vehicle with separate reporting. (3) Operating leverage: organic growth of 5–8% on a maintenance-heavy revenue base drops to FCF at high incremental margins. Key risks: acquisition multiple inflation in VMS (crowded by PE entrants), deterioration in renewal rates below 90%, management succession at Vela Trading (key operator).

Valuation: Price target based on a sum-of-the-parts applying 25× NTM owner earnings to the legacy CSU portfolio plus a 20× multiple on Topicus (faster growth, higher reinvestment). Bull case assumes sustained 30%+ ROIC and accelerating deployment; bear case reflects acquisition slowdown and multiple compression to 18× FCF.

Research Infrastructure · Coverage Tooling · Evidence Discipline

Corroborate: the machinery behind the coverage.

The event record and scoring engine underneath these reports. Every rating derives from a published rubric and traces to a primary filing, so the reasoning can be audited rather than taken on faith.

Method: a score out of 100 built from valuation, quality, trend and competitive position, with the classification a function of the score rather than a separate judgement. Where the two disagree the score governs, because a rating that contradicts its own rubric is the first thing a reader should reject.

Degenerate fields are handled explicitly. A P/E on negative shareholders' equity is not informative and is treated as such, and an ROE of 337% is read against the debt-to-equity ratio driving it. Peer comparison is by GICS sector against a reported median with the peer count stated. The bear case is built on the weakest number in the file rather than a generic risk, and the record covers 63,505 events across five years of filings and macro data.

Report 02 · Energy · CNQ:CN · TSX · Published May 2026

Canadian Natural Resources (CNQ): long-life, low-decline oil sands; premium asset quality, balanced valuation.

Hold. CNQ is Canada's highest-quality oil sands franchise: 31-year proved RLI, 26 consecutive years of dividend growth, C$15.5bn AFF in FY2025. Current price near C$63 still reflects the premium; the blended target of C$61.25 implies 3.3% downside.

Investment thesis: CNQ's integrated oil sands and conventional asset base generates sector-leading FCF underpinned by one of the lowest sustaining-capex profiles in oil sands (~C$9–14/boe). The capital returns framework is tiered by net debt milestone: at Q1'26 net debt of C$16.2bn the company has entered Milestone 2, directing 75% of excess FCF to buybacks, with a path toward C$13bn (Milestone 3: 100% FCF to returns) within 12–18 months at base-case WTI. FY2025 production of 1.57 MMBOE/d reached a record, and FY2026 guidance of 1.615–1.665 MMBOE/d with C$6.0bn capex implies continued FCF accretion.

Hold rationale: CNQ trades at 10.6× EV/EBITDA, a 25% premium to the Canadian energy peer median of ~8.5×. This premium is justified by the reserve-life advantage and returns discipline, but already embedded in the current price. Our blended valuation (40% EV/EBITDA peer-median, 40% P/FCF, 20% consensus) supports C$61.25. We would become constructive at C$55–58. Key risks: WTI below $55, WCS differential widening above $20, carbon policy escalation, pipeline disruption.

Report 03 · Medtech · ISRG:US · NASDAQ

Intuitive Surgical (ISRG): tariff noise masking a durable recurring-utilization platform.

Buy. Tariff headwinds (~US$250M, FY2026-specific per management) are masking 84–86% recurring revenue, da Vinci 5 replacement-cycle tailwinds, and 16–19% OUS procedure growth. At US$421, 31% below the 52-week high, the risk/reward is compelling.

Investment thesis: ISRG's 11,400+ installed da Vinci systems generate recurring I&A and service revenue at ~68–70% gross margins, compounding as procedures grow 15–18% annually. Da Vinci 5, at 54% of Q1'26 placements, is driving I&A revenue per procedure expansion from $1,810 toward $1,940 over the next 2–3 years. The Ion endoluminal platform (1,041 systems; procedures +39%) adds a second compounding platform. ISRG holds a net cash position of ~US$10.2bn with no financial debt. Our FY2026E non-GAAP EPS of US$10.20 (+14%) and FY2027E of US$11.80 (+16%) support the thesis that tariff headwinds are transitional, not structural.

BUY rationale: At US$421 (~56× NTM FCF), we are not calling for multiple expansion; we are calling for earnings growth of 14–16% to compound to a US$582 price. Competitive risk (Medtronic Hugo, J&J Ottava) is 5–7 years from meaningful market share displacement; ISRG's surgeon-training moat with 10,000+ certified surgeons globally is not replicable short-term. Key risks: multiple compression, tariff escalation beyond guidance, hospital capex cycles, reimbursement pressure.

Report 04 · Materials / Gold · AEM · TSX & NYSE · Initiated Q1 2026

Agnico Eagle Mines (AEM): premier low-risk gold franchise, with the quality already in the price.

Hold. Agnico is the highest-quality senior gold producer: 3.45 Moz at US$1,339 AISC in 2025, a record 55.4 Moz reserve base, and assets concentrated in Canada, Finland, and Australia. Record free cash flow and a 12.5% dividend increase reward holders, but at ~US$155 a premium multiple and a flat production profile leave a balanced risk/reward.

Investment thesis: Agnico pairs the lowest geopolitical-risk asset base among senior gold producers with sector-leading execution. FY2025 payable production of 3.45 Moz at total cash costs of US$979/oz and AISC of US$1,339/oz turned the gold rally into record free cash flow and US$1.4bn of shareholder returns, capturing roughly 95% of the gold-price move at the margin. Proven and probable reserves rose 2% to a record 55.4 Moz and indicated resources rose 10% to 47.1 Moz, extending mine life across Detour Lake, Canadian Malartic and the Odyssey underground, and the Nunavut platform organically rather than by acquisition. Sustained debt reduction leaves the balance sheet near net-cash.

Hold rationale: The case is high quality and well understood. FY2026 guidance holds production flat at 3.3–3.5 Moz while AISC steps up to US$1,400–1,550 (midpoint US$1,475), close to 10% cost inflation that compresses incremental margin if gold stalls. At ~US$155 AEM trades at a premium P/NAV and EV/EBITDA to the senior gold peer set, a premium we view as earned on jurisdiction and execution but largely captured. We would turn constructive on a pullback toward US$135–140, or on evidence of per-share growth beyond the flat 2026–2028 plan. Key risks: a reversal in the gold price, AISC inflation above guidance, and the absence of organic volume growth.

Update (Jul 22, 2026): AEM has pulled back to about US$142 from the ~US$155 level at initiation, into the US$135–140 zone flagged for a more constructive stance. At current levels the risk/reward screens closer to balanced-to-favourable, though the flat 2026–2028 volume profile and stepped-up AISC keep the rating at Hold pending evidence of per-share growth.

Report 05 · Consumer Services · HRB:US · NYSE · US Small/Mid Cap

H&R Block (HRB): a signed, guaranteed tax return, valued at 7x earnings.

Buy. 7.0x trailing earnings, a 13.4% free cash flow yield, and a 36% return on invested capital. The stock fell with Intuit on an AI-disruption thesis that misreads a liability-transfer business where a person must legally sign the return.

The mispricing: after Goldman published math showing AI can process a return for about $0.12, Intuit became the worst stock in the S&P 500 in 2026, down 46%, and H&R Block declined from $57. The customer pays for a signed return and an audit guarantee, backed by a counterparty who answers to the IRS. By law the signer must be a person: a PTIN is issued only to an individual, and Treas. Reg. 1.6695-1(b)(1) requires an individual signing preparer as the paid preparer of record.

The one number: the terminal decline rate. Flat volume, 3-4% price growth, and a 5.5% annual share-count reduction produce 8-10% EPS growth, which FY26 delivered (assisted company-owned volume 2.1%, price 3.9%). The screen: about forty US names under $10B with sustained ROIC above 15%, capital intensity under 5% of revenue, net debt under 1.5x EBITDA, and under 30x earnings, narrowed to names where I could state the belief moving the price and why it is wrong.

Report 06 · Financials / E&S Insurance · KNSL:US · NYSE · US Small/Mid Cap

Kinsale Capital (KNSL): 3.99x book, the cheapest in its public life, after a 0.5% premium dip.

Buy. The low-cost operator in excess and surplus insurance, running a 10.3% expense ratio against over 30% for MGA-fronted competitors, an 81.5% ex-catastrophe combined ratio, and a 24% operating ROE. It de-rated from about 12x book to 3.99x on a single quarter's small premium decline.

The mispricing: the market treated a deliberate pullback in underwriting as a structural decline. Q1 2026 produced the first gross-written-premium drop in company history, down 0.5%, and the stock de-rated from roughly 12x book to 3.99x against a 6.61x ten-year median. Kinsale writes small, unusual policies (a trampoline park, a demolition contractor) averaging about $12,200 each, underwrites in-house, and avoids the 15-25% MGA overrides its competitors pay. Founder Michael Kehoe has run it since 2009 and owns roughly $300M of the stock.

The other income source: a $5.1B investment portfolio against $1.97B of equity generates net investment income growing 26.5%, independent of the underwriting cycle, with essentially zero net debt. The screen: the same filter of US names under $10B, sustained ROIC above 15%, low capital intensity, low leverage, and under 30x earnings.

Independent Research · Covered-Call ETFs · CFA Society Toronto / Hillsdale

The Covered-Call Yield Illusion: the distribution is largely a return of the investor's own capital.

Award-recognized independent research. The high distribution yield on covered-call ETFs is substantially a return of the investor's own capital, though the market prices and markets it as income.

The thesis: the headline yield on a covered-call ETF combines genuine option premium with a return of the investor's capital, and the marketing reports the two as one figure. The paper decomposes the distribution and tests it against fund data, quantifying how much of the advertised income is capital coming back and how much is genuine yield. It is the consensus-challenging work a value process asks for: a widely held belief, built into how these products are sold, that the arithmetic overturns.

Real Estate · Acquisition Underwriting · Excel & Python

Cornerstone: a multifamily acquisition, underwritten from the rent roll to the return.

A 200-unit stabilized multifamily asset acquired for $47M. The model builds the pro forma to NOI, values it on a cap rate, sizes and amortizes the debt, runs the hold, and computes the return an investment committee asks for.

The build: gross potential rent through vacancy and other income to NOI, a 6.01% going-in cap against a 5.25% debt rate so leverage is accretive, a loan sized to a 1.50x minimum DSCR and a 10.02% debt yield, and an exit on a forward cap held flat to entry. The base case underwrites to a 12.6% levered IRR, an 8.6% unlevered IRR, and a 1.74x equity multiple over five years, with the return driven by NOI growth and amortization rather than cap-rate compression.

Method: a two-factor sensitivity isolates the dominant risk, exit-cap expansion, against rent growth. Figures are illustrative and every assumption is transparent, so a reader can change one input and see the return recompute. Built on standard underwriting conventions after Geltner and Miller, with NCREIF and ULI market references.